|
Video: What is a Stock Split?
|
|
TFF Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing technology platform. Co. has two product candidates under development, TFF Voriconazole Inhalation Powder and TFF Tacrolimus Inhalation Powder. Co. is engaged in the analysis and testing of dry powder formulations of several drugs and vaccines through parenteral, topical, ocular, pulmonary and nasal applications through feasibility studies and material transfer agreements with U.S. and international pharmaceutical companies and certain government agencies. According to our TFF Pharmaceuticals stock split history records, TFF Pharmaceuticals has had 1 split. | |
|
TFF Pharmaceuticals (TFFP) has 1 split in our TFF Pharmaceuticals stock split history database. The split for TFFP took place on December 19, 2023. This was a 1 for 25 reverse split, meaning for each 25 shares of TFFP owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 40 share position following the split.
When a company such as TFF Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the TFF Pharmaceuticals stock split history from start to finish, an original position size of 1000 shares would have turned into 40 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into TFF Pharmaceuticals shares, starting with a $10,000 purchase of TFFP, presented on a split-history-adjusted basis factoring in the complete TFF Pharmaceuticals stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/28/2019 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$126.00 |
|
End price/share: |
$6.59 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-94.77% |
|
Average Annual Total Return: |
-48.73% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$523.15 |
|
Years: |
4.42 |
|
|
|
Date |
Ratio |
12/19/2023 | 1 for 25 |
|
|